140 related articles for article (PubMed ID: 2404388)
1. A double-blind randomized multicenter dose-ranging trial of intravenous streptokinase in acute myocardial infarction.
Six AJ; Louwerenburg HW; Braams R; Mechelse K; Mosterd WL; Bredero AC; Dunselman PH; van Hemel NM
Am J Cardiol; 1990 Jan; 65(3):119-23. PubMed ID: 2404388
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.
Rogers WJ; Mantle JA; Hood WP; Baxley WA; Whitlow PL; Reeves RC; Soto B
Circulation; 1983 Nov; 68(5):1051-61. PubMed ID: 6352081
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
Théroux P; Pérez-Villa F; Waters D; Lespérance J; Shabani F; Bonan R
Circulation; 1995 Apr; 91(8):2132-9. PubMed ID: 7697841
[TBL] [Abstract][Full Text] [Related]
5. Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group.
Lancet; 1989 Apr; 1(8643):863-8. PubMed ID: 2564949
[TBL] [Abstract][Full Text] [Related]
6. Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction.
Hogg KJ; Gemmill JD; Burns JM; Lifson WK; Rae AP; Dunn FG; Hillis WS
Lancet; 1990 Feb; 335(8684):254-8. PubMed ID: 1967720
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ
Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357
[TBL] [Abstract][Full Text] [Related]
8. [Systemic thrombolysis with short-term streptokinase infusion in acute myocardial infarct].
Schröder R; Biamino G; von Leitner ER; Linderer T; Heitz J; Vöhringer HF; Wegscheider K; Andresen D; Arntz HR; Brüggemann T; Grassot A; Lichey J; Oeff M; Prokein E; Schäfer JH; Sörensen R
Z Kardiol; 1982 Nov; 71(11):709-18. PubMed ID: 7157926
[TBL] [Abstract][Full Text] [Related]
9. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
[TBL] [Abstract][Full Text] [Related]
10. [Anisoylated plasminogen streptokinase complex during the acute phase of myocardial infarction. Results of a multicenter double-blind study versus heparin].
Cassagnes J; Bassand JP; Machecourt J; Lusson JR; Anguenot T; Borel E; Vacher D; Denis B; Maurat JP; Jallut H
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):453-60. PubMed ID: 2111665
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
Ghaffari S; Kazemi B; Golzari IG
Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
[TBL] [Abstract][Full Text] [Related]
12. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
[TBL] [Abstract][Full Text] [Related]
13. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
Rothbard RL; Anderson JL; Fitzpatrick PG; Hakworthy RA; Sorensen SG; Marder VJ
Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
[TBL] [Abstract][Full Text] [Related]
14. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.
Bassand JP; Machecourt J; Cassagnes J; Anguenot T; Lusson R; Borel E; Peycelon P; Wolf E; Ducellier D
J Am Coll Cardiol; 1989 Apr; 13(5):988-97. PubMed ID: 2647817
[TBL] [Abstract][Full Text] [Related]
15. Intravenous streptokinase in acute myocardial infarction (I.S.A.M.): assessment of left ventricular function 1 and 7 months after infarction by radionuclide ventriculography.
Voth E; Tebbe U; Schicha H; Neumann P; Schröder R; Neuhaus KL; Emrich D
Eur Heart J; 1990 Oct; 11(10):885-96. PubMed ID: 2265640
[TBL] [Abstract][Full Text] [Related]
16. High-dose, brief intravenous streptokinase early in acute myocardial infarction.
Spann JF; Sherry S; Carabello BA; Mann RH; McCann WD; Gault JH; Gentzler RD; Rosenberg KM; Maurer AH; Denenberg BS; Warner HF; Rubin RN; Malmud LS; Comerota A
Am Heart J; 1982 Oct; 104(4 Pt 2):939-45. PubMed ID: 6751060
[TBL] [Abstract][Full Text] [Related]
17. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex.
Kasper W; Meinertz T; Wollschläger H; Bonzel T; Wolff P; Drexler H; Hofmann T; Zeiher A; Just H
Am J Cardiol; 1986 Sep; 58(6):418-21. PubMed ID: 3529908
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.
Grines CL; Nissen SE; Booth DC; Gurley JC; Chelliah N; Wolf R; Blankenship J; Branco MC; Bennett K; DeMaria AN
Circulation; 1991 Aug; 84(2):540-9. PubMed ID: 1907228
[TBL] [Abstract][Full Text] [Related]
19. A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
Grines CL; Nissen SE; Booth DC; Branco MC; Gurley JC; Bennett KA; DeMaria AN
J Am Coll Cardiol; 1989 Sep; 14(3):573-80. PubMed ID: 2504797
[TBL] [Abstract][Full Text] [Related]
20. A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity.
Schröder R; Neuhaus KL; Leizorovicz A; Linderer T; Tebbe U
J Am Coll Cardiol; 1987 Jan; 9(1):197-203. PubMed ID: 3540072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
